XML 98 R27.htm IDEA: XBRL DOCUMENT v2.4.1.9
CONCENTRATIONS
12 Months Ended
Dec. 31, 2014
Risks and Uncertainties [Abstract]  
Concentration Risk Disclosure [Text Block]
19.
CONCENTRATIONS
 
Major Customers
 
For the year ended December 31, 2014, 2013 and 2012, approximately 20%, 26% and 13% of the Company’s revenues were received from two major customers.
 
At December 31, 2014, receivables from one customer were approximately 10% of the total accounts receivable at December 31, 2014. No customer represented more than 10% of accounts receivable at December 31, 2013 and 2012, respectively.
 
Major Suppliers
 
For the year ended December 31, 2014, 2013 and 2012, purchases from three suppliers were approximately 62%, 83% and 86% of the total purchase, respectively.
 
Revenues
 
For the years ended December 31, 2014, 2013 and 2012, the Company’s top three selling products accounted, in the aggregate, for approximately 72%, 67% and 68%, respectively, of its total net revenues.
  
The following represents the revenues by product line, all derived from China:
 
 
 
For the years ended
 
 
 
December 31,
 
 
 
2014
 
2013
 
2012
 
 
 
US$
 
US$
 
US$
 
Products Line
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medical Devices
 
 
10,302,024
 
 
14,824,028
 
 
18,547,635
 
Respiratory and Oxygen Homecare
 
 
53,755
 
 
2,034,150
 
 
2,822,690
 
Mobile medicine
 
 
1,633,667
 
 
-
 
 
-
 
 
 
 
11,989,446
 
 
16,858,178
 
 
21,370,325